Rakuten Securities’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.36K Buy
+23
New +$4.33K ﹤0.01% 564
2026
Q1
Sell
-710
Closed -$131K 891
2025
Q4
$131K Sell
710
-77
-10% -$13.5K 0.04% 154
2025
Q3
$121K Sell
787
-198
-20% -$30K 0.04% 178
2025
Q2
$138K Buy
985
+229
+30% +$32.1K 0.05% 147
2025
Q1
$111K Buy
756
+345
+84% +$49.9K 0.06% 152
2024
Q4
$53.9K Sell
411
-34
-8% -$4.76K 0.02% 202
2024
Q3
$69.3K Sell
445
-196
-31% -$31.6K 0.03% 162
2024
Q2
$99.9K Sell
641
-371
-37% -$55.8K 0.04% 127
2024
Q1
$137K Sell
1,012
-18
-2% -$2.38K 0.06% 115
2023
Q4
$139K Buy
+1,030
New +$134K 0.11% 108

Other funds holding AZN

Rakuten Securities's AZN Position: Q2 2026 in Review

Rakuten Securities opened a new position in AstraZeneca (AZN) in Q2 2026: 23 shares worth $4.36K. The stake represents ﹤0.01% of the portfolio and ranks #564 among its holdings. This is a return to the name: Rakuten Securities previously reported a position in AZN as recently as Q4 2025.

Rakuten Securities first reported a position in AZN in Q4 2023 and has held it in 10 quarters since. The position peaked at $139K in Q4 2023. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Rakuten Securities held 23 shares of AstraZeneca worth $4.36K as of Q2 2026.
  • AstraZeneca was a new Rakuten Securities position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #564 holding.
  • Rakuten Securities first reported a position in AstraZeneca in Q4 2023 and has held it in 10 quarters since.
  • Rakuten Securities's AstraZeneca position peaked at $139K in Q4 2023.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.